1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

who's dumb enough to accept job offers from Actavis?

Discussion in 'Forest Lab Personnel' started by Anonymous, Jan 18, 2015 at 11:20 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Is anyone actually stupid enough to say yes?
     

  2. Anonymous

    Anonymous Guest

    YES